Novartis (Japan)

450 papers and 9.9k indexed citations i.

About

In recent decades, authors affiliated with Novartis (Japan) have published 450 papers, which have received a total of 9.9k indexed citations. Scholars at this organization have produced 149 papers in Molecular Biology, 86 papers in Oncology and 65 papers in Pulmonary and Respiratory Medicine on the topics of Asthma and respiratory diseases (39 papers), Proteoglycans and glycosaminoglycans research (21 papers) and Respiratory and Cough-Related Research (20 papers). Their work is cited by papers focused on Molecular Biology (4.0k citations), Oncology (1.7k citations) and Cell Biology (1.6k citations). Authors at Novartis (Japan) collaborate with scholars in Japan, Switzerland and United States and have published in prestigious journals including New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology. Some of Novartis (Japan)'s most productive authors include Motowo Nakajima, Minako Toyoshima, Daisaku Ohta, Shinichi Koizumi, Masaharu Mizutani, Jian Dong, Sohei Kitazawa, Kazuo Gohji, Hiroyuki Akita and Shinji Hatakeyama.

In The Last Decade

Fields of papers published by authors at Novartis (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (Japan) at the time of their publication.

Countries citing scholars working at Novartis (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025